Healthcare Reforms Aimed at Preventing Genetic Disorders from Being Passed On to Future Generations Drives the Importance of Prenatal Diagnostics in Maternal Healthcare
The global market for Prenatal Diagnostics is projected to reach US$6.8 billion by 2022 , driven by delayed pregnancies, rising incidence of chromosomal anomalies in the fetus causing Down’s syndrome and other disorders, and technological improvements that minimize false negatives and enhance accuracy in results. Prenatal testing involves screening and diagnostic methods carried out during pregnancy for various purposes, such as determination of fetal sex and identification of potential genetic and chromosomal abnormalities of the fetus. cff-DNA refers to cell-free fetal DNA, which escapes into the maternal blood circulation via the placenta, and offers crucial information about the fetal genetic makeup and links to any potential disease. Non-Invasive Prenatal Testing (NIPT) technique analyzes cff-DNA in the maternal blood sample to detect chromosomal aneuploidies, especially trisomy of the chromosome 21, which is commonly called Down’s syndrome. NIPT is more accurate than serum...